| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/06/2010 | WO2010051105A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 05/06/2010 | WO2010050902A1 Vaccines, which combine the antigen and toll-like receptors |
| 05/06/2010 | WO2010050554A1 Immunoassay method for human cxcl1 protein |
| 05/06/2010 | WO2010050528A1 Anti-muc1 antibody |
| 05/06/2010 | WO2010050268A1 Molecular marker for cancer stem cell |
| 05/06/2010 | WO2010050190A1 Molecular marker for cancer stem cell |
| 05/06/2010 | WO2010050167A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same |
| 05/06/2010 | WO2010049933A1 Efficient expression of truncated human rnaset2 in e. coli |
| 05/06/2010 | WO2010049777A1 An expression vector and processes thereof |
| 05/06/2010 | WO2010049672A2 Methods and products |
| 05/06/2010 | WO2010030182A3 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases |
| 05/06/2010 | WO2010029497A8 Treatment of endometriosis |
| 05/06/2010 | WO2010027423A3 Compositions of pd-1 antagonists and methods of use |
| 05/06/2010 | WO2010011357A3 Detection of prostate cancer using psa glycosylation patterns |
| 05/06/2010 | WO2010006136A3 Adenovirus targeting |
| 05/06/2010 | WO2009047360A9 Il-21 antibodies |
| 05/06/2010 | US20100115639 Antibodies inhibiting c-met dimerization and uses thereof |
| 05/06/2010 | US20100115638 Method for inhibiting the expression of endogenous erythropoietin (epo) |
| 05/06/2010 | US20100113752 Immunodisplacement Electrophoresis |
| 05/06/2010 | US20100113751 Purification of acidic proteins using ceramic hydroxyapatite chromatography |
| 05/06/2010 | US20100113750 Novel scavenger receptor |
| 05/06/2010 | US20100113749 Novel scavenger receptor |
| 05/06/2010 | US20100113748 Soluble il-17rcx4 and methods of using in inflammation |
| 05/06/2010 | US20100113747 Coupling of Antibody Polypeptides at the C-Terminus |
| 05/06/2010 | US20100113746 Process for purification of immunoglobulins using a pseudobioaffinity adsorbent |
| 05/06/2010 | US20100113745 Means and Methods for Influencing the Stability of Antibody Producing Cells |
| 05/06/2010 | US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/06/2010 | US20100113476 Chemical linkers with single amino acids and conjugates thereof |
| 05/06/2010 | US20100113361 Anti-ige vaccines |
| 05/06/2010 | US20100113340 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 05/06/2010 | US20100113339 Serum albumin binding proteins with long half-lives |
| 05/06/2010 | US20100112666 Dehalogenases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 05/06/2010 | US20100112664 Method of making macroporous cation exchange resins |
| 05/06/2010 | US20100112660 Method for Derivatization of Proteins Using Hydrostatic Pressure |
| 05/06/2010 | US20100112608 Method of diagnosing lawsonia intracellularis |
| 05/06/2010 | US20100112601 Novel monoclonal antibody and use of the same |
| 05/06/2010 | US20100112596 Kit for deciding degree of malignancy in prostate cancer and method of using the same |
| 05/06/2010 | US20100112593 Method of Predicting the Clinical Response to Chemotherapeutic Treatment with Alkylating Agents |
| 05/06/2010 | US20100112591 Tumor Suppressor Gene |
| 05/06/2010 | US20100112587 Transcriptomic biomarkers for individual risk assessment in new onset heart failure |
| 05/06/2010 | US20100112582 Gene encoding labyrinthin, a marker for cancer |
| 05/06/2010 | US20100112071 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 05/06/2010 | US20100111991 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 05/06/2010 | US20100111990 Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women |
| 05/06/2010 | US20100111980 Binding partners of antibodies specific for dendritic cell antigens |
| 05/06/2010 | US20100111979 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 05/06/2010 | US20100111978 Conjugates between a variant staphylococcal enterotoxin e superantigen and a targeting antibody that binds to a cancer-associated cell surface structure |
| 05/06/2010 | US20100111977 Methods and compositions for treatment of myotonic dystrophy |
| 05/06/2010 | US20100111975 Monoclonal Antibodies for Treatment of Cancer |
| 05/06/2010 | US20100111974 Treatment of Cachexia |
| 05/06/2010 | US20100111971 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 05/06/2010 | US20100111970 Anti-NGF Antibodies and Methods Using Same |
| 05/06/2010 | US20100111969 Il-4 receptor and il-13 as prognostic markers for colon and pancreas tumors |
| 05/06/2010 | US20100111967 Bispecific anti-vegf/anti-ang-2 antibodies |
| 05/06/2010 | US20100111966 Engineered anti-il-23p19 antibodies |
| 05/06/2010 | US20100111965 Combination therapy |
| 05/06/2010 | US20100111964 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 05/06/2010 | US20100111959 Engineered anti-il-13 antibodies, compositions, methods and uses |
| 05/06/2010 | US20100111958 Notch-Binding Agents and Antagonists and Methods of Use Thereof |
| 05/06/2010 | US20100111957 Methods of diagnosing and treating cytomegalovirus diseases |
| 05/06/2010 | US20100111956 antigen polypeptide for the diagnosis and/or treatment of ovarian cancer |
| 05/06/2010 | US20100111953 Antibodies that immunospecifically bind to b lymphocyte stimulator |
| 05/06/2010 | US20100111948 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 05/06/2010 | US20100111944 Method of diagnosing, classifying and treating endometrial cancer and precancer |
| 05/06/2010 | US20100111943 Compositions and methods for inhibiting cancer metastasis |
| 05/06/2010 | US20100111939 Monoclonal antibody and use thereof |
| 05/06/2010 | US20100111933 Acid soluble proteins from micellar casein |
| 05/06/2010 | US20100111932 Antibodies against ramp3 |
| 05/06/2010 | US20100111931 Agents, Which Inhibit Apoptosis in Cells that are Involved in Wound Healing |
| 05/06/2010 | US20100111928 Methods and kits for diagnosis tumorgenicity |
| 05/06/2010 | US20100111871 Photoacoustic probes and methods of imaging |
| 05/06/2010 | US20100111868 Monoclonal antibodies for neutralizing anthrax toxin |
| 05/06/2010 | US20100111856 Zirconium-radiolabeled, cysteine engineered antibody conjugates |
| 05/06/2010 | US20100111852 Anti-Claudin 3 Monoclonal Antibody and Treatment and Diagnosis of Cancer Using the Same |
| 05/06/2010 | US20100111851 Diagnosis and treatment of cancer by using anti-prg-3 antibody |
| 05/06/2010 | CA2779436A1 Light targeting molecules and uses thereof |
| 05/06/2010 | CA2742157A1 Immunoassay method for human cxcl1 protein |
| 05/06/2010 | CA2742014A1 Toll-like receptor 3 antagonists |
| 05/06/2010 | CA2741798A1 Anti-muc1 antibody |
| 05/06/2010 | CA2739705A1 Efficient expression of truncated human rnaset2 in e. coli |
| 05/06/2010 | CA2739568A1 Purification of acidic proteins using ceramic hydroxyapatite chromatography |
| 05/05/2010 | EP2182078A1 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| 05/05/2010 | EP2182066A2 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 05/05/2010 | EP2182065A2 Staphylococcus epidermidis antigens |
| 05/05/2010 | EP2182064A1 Gene expressed in prostate cancer |
| 05/05/2010 | EP2182008A2 Monoclonal anti alpha-D (ITGAD) antibodies for use in the treatment of inflammation |
| 05/05/2010 | EP2182006A2 Compositions and methods for the treatment of immune related diseases |
| 05/05/2010 | EP2182005A1 A gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 05/05/2010 | EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/05/2010 | EP2181714A2 Immunogenic composition for use in vaccination against staphylococcei |
| 05/05/2010 | EP2181711A1 Cancer therapy using whole glucan particles and antibodies |
| 05/05/2010 | EP2181331A1 Materials and methods for sperm sex selection |
| 05/05/2010 | EP2181122A1 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |
| 05/05/2010 | EP1702982B1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 05/05/2010 | EP1592801B1 Method for identifying activated polymer complexes for secondary site-specific modification of protein target groups. |
| 05/05/2010 | EP1572106B1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 05/05/2010 | EP1248803B1 Nogo receptor-mediated blockade of axonal growth |
| 05/05/2010 | EP0973928B1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| 05/05/2010 | EP0854917B1 Transgenic non-human animals capable of producing heterologous antibodies |
| 05/05/2010 | CN1752104B Monoclonal antibody of synapse protein gamma and its application |